News - Bertin Technologies

News

Prevent earthquake with Bertin Instruments Bertin Technologies 61569

Prevent earthquake with Bertin Instruments

05 Oct 2023

Earthquakes are natural events that are very difficult to predict and inevitably occur when certain geological conditions are met. Some researchers have suggested that soil gas emissions in seismic areas study can be used to understand the relationship between gas formation, release, and migration during earthquakes and maybe predict them. Among these gas, researchers studied […]

Bertin Technologies and the Princeton Plasma Physics Laboratory are developing of the U-WAVS system to monitor the temperature of the ITER Tokamak Bertin Technologies 61465

Bertin Technologies and the Princeton Plasma Physics Laboratory are developing of the U-WAVS system to monitor the temperature of the ITER Tokamak

02 Oct 2023

For over 4 years, Bertin Technologies and the Princeton Plasma Physics Laboratory have been working on the Upper Wide Angle Viewing System (U-WAVS) for the International Thermonuclear Experimental Reactor (ITER). Focus on Bertin’s latest contribution to the world’s largest current scientific project. Located in Cadarache, France, ITER is an international project involving 35 nations, including […]

inpi office

Bertin Technologies in the Top 5 of INPI’s Palmarès 2022

26 Sep 2023

INPI (Institut National de la Propriété Industrielle) has published its 2022 regional ranking of leading patent applicants, which highlights the economic players – large companies, ETIs, SMEs and research, higher education and government establishments – who contribute to innovation in the regions. In 2022, 438 patent applications published at INPI came from corporate applicants with […]

CamSight LP successfully tested by engineering students of Formula Student competition Bertin Technologies 61235

CamSight LP successfully tested by engineering students of Formula Student competition

20 Sep 2023

Last Summer, CamSight LP – Low Power thermal camera module – has been successfully tested by engineering students of the RWTH Aachen University, which is one of Europe’s leading science and research institutions, as part of the Formula Student Challenge. Formula Student is an international engineering competition, which aims at providing students with a platform […]

Bertin Health & Life Sciences is attending to the ARABLab show for the first time! Bertin Technologies 60937

Bertin Health & Life Sciences is attending to the ARABLab show for the first time!

06 Sep 2023

ArabLab is an internationally recognised exhibition in the field of laboratory technology and analysis, ranking among the most important events in its industry worldwide. Bertin Health & Life Sciences’ team is very excited to exchange around our innovative laboratory equipment for sample preparation  & air-borne contamination control as well as our biomarkers analysis reagents. Don’t miss […]

Bertin Technologies is ready for DSEI 2023 Bertin Technologies 60750

Bertin Technologies is ready for DSEI 2023

30 Aug 2023

From September 12th to 15th, Bertin Technologies will attend DSEI 2023, organised at the ExCeL centre in London. Join us at booth H2-710 (UK Pavilion) for this edition that promises to be full of opportunities. DSEI is one of the biggest shows for the global Defense & Security market. Industry leaders, armed forces members, decision-makers: […]

Bertin Technologies contributes to the rescEU European program for the provision of CBRN detection and civil protection equipment Bertin Technologies 60701

Bertin Technologies contributes to the rescEU European program for the provision of CBRN detection and civil protection equipment

30 Aug 2023

As a firmly European French company, Bertin Technologies is proud to contribute to the supply of equipment for the detection and identification of Chemical, Biological, Radiological and Nuclear (CBRN) threats. In February 2023, France was awarded a budget of 150 million euros by the European Commission to amass and maintain stocks of health products (medicine, […]

[ARTICLE] Find out how Coriolis µ was used to monitor Legionellosis in healthcare facilities Bertin Technologies 60140

[ARTICLE] Find out how Coriolis µ was used to monitor Legionellosis in healthcare facilities

02 Aug 2023

Legionellosis in healthcare facilities: state of the art in control and prevention in Italy   Legionella pneumophila is an intracellular bacteria responsible for causing Legionnaires’ disease, a severe form of pneumonia. Prompt identification, diagnosis, and treatment are essential to manage this potentially life-threatening infection. Nosocomial water systems are often contaminated by Legionella. Active, well-planned clinical […]

Fruitful collaboration between Bertin Technologies and the Institute for Neutron Physics and Reactor Technology for IFMIF-DONES fusion program Bertin Technologies 60237

Fruitful collaboration between Bertin Technologies and the Institute for Neutron Physics and Reactor Technology for IFMIF-DONES fusion program

27 Jul 2023

Since 2022, Bertin Technologies and the Institute for Neutron Physics and Reactor Technology (INR) at Karlsruhe Institute of Technology (KIT) collaborate as part of their respective activities on ITER and IFMIF-DONES, two major fusion programs. Focus on their collaboration based on IVVS, developed by Bertin Technologies for Fusion for Energy. After successfully testing a prototype, […]

Discover our top-selling Precellys kits! Bertin Technologies 59882

Discover our top-selling Precellys kits!

24 Jul 2023

For many years, scientists all around the globe have been using Precellys lysing and grinding kits, as they have been proven efficient and safe in a broad range of research areas including microbiology, pharmacology, cancer, forensic medicine, the environment, and even agronomy. Here below, discover our top three bestselling kits and find the perfect solution […]

ANY QUESTIONS? CONTACT AN EXPERT

Please fill in this form if you wish to contact our sales team or receive further information.

My Account
Forgot password ?

Add a question !

Add a question